39 studies found for:    " June 26, 2013":" July 26, 2013"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
Download search resultsDownload the search results for:
" June 26, 2013":" July 26, 2013"[FIRST-RECEIVED-DATE]AND HIV[CONDITION] (39 records)
Download Content:
Zip file readers with free trial periods: WinZip or PKZip
Rank Status Study
1 Terminated Evaluation of a Blood Test to Measure Immune Function in HIV Positive People Compared With HIV Negative People
Condition: HIV Positive
2 Recruiting Oligonucleotide Ligation Assay (OLA) Resistance Study
Condition: HIV Positive
Intervention: Other: Pre-ART Oligonucleotide Assay (OLA)
3 Completed Evaluation of the Impact of Mobile Phone Messages on ART and PMTCT Adherence in Mozambique
Condition: HIV-positive
Intervention: Behavioral: SMS reminders
4 Active, not recruiting Link4Health: A Combination Strategy for Linkage and Retention, Swaziland
Condition: HIV (Human Immunodeficiency Virus)
Interventions: Procedure: POC (point-of-care) CD4+ (cluster of differentiation 4) Count;   Procedure: Accelerated ART (antiretroviral therapy) Initiation;   Behavioral: Basic Care and Prevention Package;   Behavioral: Cellular Appointment Reminders and Follow-Up;   Other: Financial Incentive
5 Unknown  Treatment With Probiotics (Saccharomyces Boulardii) and Its Role in Bacterial Translocation and Immune Reconstitution in HIV Infection.
Condition: HIV -1 Infection
Interventions: Dietary Supplement: Probiotic.;   Dietary Supplement: Placebo
6 Recruiting Evaluation of a Maintenance Strategy With Protease Inhibitors With or Without Lamivudine in Virologically Suppressed HIV Patients on Second Line Antiretroviral Treatment in Africa
Condition: HIV Infection
Interventions: Drug: monoPI - boosted lopinavir or boosted darunavir;   Drug: bi therapy - (boosted lopinavir or boosted darunavir) + lamivudine
7 Completed Hepatic Safety of Currently Used Antiretroviral Regimens in Patients With Chronic Hepatitis Under Real Life Conditions
Conditions: Human Immunodeficiency Virus;   Hepatitis B, Chronic;   Hepatitis C, Chronic
Intervention: Drug: antiretroviral drugs
8 Active, not recruiting A Study to Determine Safety and Efficacy of Dolutegravir/Abacavir/Lamivudine (DTG/ABC/3TC) in Human Immunodeficiency Virus (HIV)-1 Infected Antiretroviral Therapy (ART) Naïve Women (ARIA)
Condition: Infection, Human Immunodeficiency Virus
Interventions: Drug: Dolutegravir/abacavir/lamivudine FDC;   Drug: Atazanavir;   Drug: Ritonavir;   Drug: Tenofovir/emtricitabine FDC
9 Completed Male Engagement in PMTCT Services
Condition: HIV
Interventions: Other: clinic based intervention;   Other: clinic and community based intervention
10 Active, not recruiting Maternal HIV Disclosure to School Children: RCT of Family-based Intervention
Conditions: HIV;   Disclosure
Intervention: Behavioral: Amagugu Counseling Intervention
11 Unknown  Investigating Immunisation Strategies of DNA, MVA and CN54rgp140 Adjuvanted With GLA-AF to Maximise Antibody Responses
Condition: HIV
Interventions: Biological: DNA;   Biological: MVA-C;   Biological: CN54rgp140;   Biological: GLA-AF
12 Completed Mfangano Island Healthy Networks Impact Study
Condition: HIV
Intervention: Behavioral: Mfangano Health Net Microclinic Program
13 Completed Prospective HIV Chemotherapy Cohort Study
Conditions: HIV;   Cancer
Intervention: Other: No intervention for this study
14 Unknown  Relaxation, Depressive Symptoms, Quality of Life, Immunological and Virological Status in People Living With HIV: a Pilot Study
Conditions: HIV;   Depressive Symptoms
Interventions: Behavioral: Jacobson progressive muscular relaxation;   Behavioral: Schultz's autogenic training
15 Recruiting Same-Day HIV Testing and Treatment Initiation to Improve Retention in Care
Condition: HIV
Interventions: Other: Same-Day HIV testing and ART initiation;   Other: Standard ART Initiation;   Other: Sub-Study: Same-Day ART, CD4 Count >500;   Other: Sub-Study: Standard Pre-ART Care, CD4 Count >500
16 Recruiting Switch to Maraviroc + Integrase Inhibitor
Condition: HIV
Intervention: Drug: Switch to Maraviroc + Raltegravir or Dolutegravir
17 Completed Adapting and Evaluating an EBI to Prevent HIV/AIDS Risk Among Apache Youth
Condition: HIV/AIDS
Interventions: Behavioral: Focus On Youth;   Behavioral: Health Education Control Condition
18 Recruiting Swaziland Safe Generations
Condition: HIV/AIDS
Intervention: Other: Option B+
19 Recruiting Bone Mineral Density Changes in HIV-positive Females With Osteopenia Switching to Raltegravir
Conditions: HIV Infection;   Osteopenia
Interventions: Drug: raltegravir and atazanavir and ritonavir;   Drug: tenofovir/emtricitabine and atazanavir and ritonavir
20 Unknown  Viral Biofilms: Hijacking T Cell Extracellular Matrix to Regulate HIV-1 Spread?
Condition: HIV Infection
Intervention: Other: Blood sample

   Previous Page Studies Shown (1-20) Next Page (21-39) Show next page of results    Last Page
Indicates status has not been verified in more than two years